Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Single nucleotide polymorphisms predict the change in left ventricular mass in response to antihypertensive treatment.

Journal of hypertension - 1 Dec 2004

Liljedahl Ulrika, Kahan Thomas, Malmqvist Karin, Melhus Håkan, Syvänen Ann-Christine, Lind Lars, Kurland Lisa

Abstract excerpt

BACKGROUND: Our aim was to determine whether the change in left ventricular (LV) mass in response to antihypertensive treatment could be predicted by multivariate analysis of single nucleotide polymorphisms (SNPs) in candidate genes reflecting pathways likely to be involved in blood pressure control. METHODS: Patients with mild to moderate primary hypertension and LV hypertrophy were randomized in a double-blind...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenergic beta-Antagonists
Share to Angiotensin II Type 1 Receptor Blockers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Angiotensinogen

Share to Antihypertensive Agents

Share to Biphenyl Compounds

Share to Hypertrophy, Left Ventricular

Share to Receptors, Adrenergic, beta-2

Share to Tetrazoles

Source

Identifiers

PMID: 15614026
DOI: 10.1097/00004872-200412000-00014

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Single nucleotide polymorphisms predict the change in left ventricular mass in response to antihypertensive treatment.PMID 15614026Read ↗

Angiotensinogen gene polymorphisms: relationship to blood pressure response to antihypertensive treatment. Results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial.Semantic proximity Read ↗

Single nucleotide polymorphisms in the apolipoprotein B and low density lipoprotein receptor genes affect response to antihypertensive treatment.Semantic proximity Read ↗

Polymorphisms in the angiotensinogen and angiotensin II type 1 receptor gene are related to change in left ventricular mass during antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial.Semantic proximity Read ↗

A microarray minisequencing system for pharmacogenetic profiling of antihypertensive drug response.Semantic proximity Read ↗

The relationship between the plasma concentration of irbesartan and the antihypertensive response is disclosed by an angiotensin II type 1 receptor polymorphism: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs. Atenolol (SILVHIA) Trial.Semantic proximity Read ↗

A Single Nucleotide Polymorphism near the CYP17A1 Gene Is Associated with Left Ventricular Mass in Hypertensive Patients under Pharmacotherapy.Semantic proximity Read ↗

Genetic variants predicting left ventricular hypertrophy in a diabetic population: a Go-DARTS study including meta-analysis.Semantic proximity Read ↗

Genetic variations associated with echocardiographic left ventricular traits in hypertensive blacks.Semantic proximity Read ↗

Genome-wide meta-analysis of SNP and antihypertensive medication interactions on left ventricular traits in African Americans.Semantic proximity Read ↗

Transforming growth factor beta1 genotype and change in left ventricular mass during antihypertensive treatment--results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).Semantic proximity Read ↗

Pharmacogenetics in heart failure: genomic markers of endothelial and neurohumoral function.Semantic proximity Read ↗

The CYP2C9 genotype predicts the blood pressure response to irbesartan: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.